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BenzilideneBenzylamine the derivative of Schiff bases contain azomethine group already used widely for 
industrial purposes and have wide range of biological activities. Benzilidene Benzylamine were 
synthesized by microwave irradiation reacting different aromatic and aniline purified pure crystal, 85% 
yield obtained reaction monitor by TLC. The Anticholinesterase activity utilized spectrophotometric 
Ellman assay for determination of butyrylcholinesterase and acetylcholinesterase. The synthesis 
compound 1-6 showed a wide range of inhibitory activity the compound 3((E)-N-(4-
fluorobenzylidene)aniline) at 1000µg/mL, 71.62±0.74 percent inhibitory acetylcholinesterase potential 
while compound 6 ((E)-4 ((phenylimino)methyl) benzaldehyde) at 500 and 1000 µg/mL at IC50 show 
71.68±0.22, 77.84±0.32 percent inhibitory potential comparatively greater than standard Galanthamine at 
62.5µg/mL, 74.10±0.90 at IC50. The butyrylcholinesterase activity of compound 6 ((E)-4 
((phenylimino)methyl)benzaldehyde) at 1000 µg/mL, show 75.83±1.07 percent inhibitory potential which 
is similar to standard compound at 62.5 µg/mL concentration of 75.45±0.90 percent butyrylcholinesterase 
inhibitory activity. 
 








A German scientist Alois Alzheimer in 1907 
discovered a disease of central nervous system in 
which degeneration and dysfunction of neuron cell 
occur. This disease is named after Alois Alzheimer 
as Alzheimer disease (AD).Later on it was come 
to know that this disease effect more than twenty 
million people all over the world and rank 3rd 
after cancer and cardiac disease [1].The patient 
who suffer from (AD) at their early stages can be 
diagnosis by decrease in cerebral function, short 
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term memory loss. This make the victim 
incompetent to speak, read and think properly in 
later stages of the disease [2]. The current study 
which are though hypothetical propose a 
cholinergic pathway give stress on decrease in 
acetylcholine (ACh) in brain due to hydrolysis by 
acetylcholinesterase enzyme (AChE) [2,3]. 
Butyrylcholinesterase have the same function as 
actylcholinesterase, deactivate acetylcholine in 
brain. With the decrease of acetylcholine in brain 
the activity of acetylcholinesterase also decrease. 
Unlike, AChE Butyrylcholinesterase maintain at 
optimum level or above. Therefore 
Butyrylcholinesterase is an important factor of 
decrease of acetylcholine in brain [4]. Along with 
this Butyrylcholinesterase inhibition also decrease 
ᵦ-amyloid peptide [5, 6]. The symptoms of (AD) 
are matured by Butyrylcholinesterase [7]. The 
selective inhibition of Butyrylcholinesterase in later 
stages of disease further decrease mental abilities 
due to dysfunctioning of neurons. Thus targeted 
acetylcholinesterase and Butyrylcholinesterase 
inhibitors open new routes for control measure of 
Alzheimer disease. 
 Many researchers workout for discovering 
drugs to minimize or demolish Alzheimer disease 
which have no side effects and usual. Tacrine is one 
of the common drug use for treating Alzheimer 
disease but due to its side effects their use become 
limited. Beside Tacrine other drugs used for AD are 
Rivastigmine, Donepezil, Memantine, 
Galanthamine and Caproctamine. None of these 
drugs are without side effects and may cause 
dizziness, diarrhea, gastro problems, hepato-
toxicty, vomiting, nausea etc [7-10]. The free 
radical produce oxidative stress in cell due to 
disproportionation of anti-oxidants which are 
involve in many diseases [11]. This give the idea 
that control measure of excessive free radical in cell 
which are captured by AChE, BChE inhibitor and 
anti-oxidants should be used for treatment of 
Alzheimer disease [12,13]. Along with this the 
literature study show that polyamine derivatives 
present in larg number of standard drugs while 
Acetylcholinesterase and Butyrylcholinesterase 
contain aromatic rings residues that have 
capability to form positive(+ve)-π bond with 
basic polyamine counterpart [14,15]. 
Our current study is based o preparation and 
characterization of other such compounds that 
have capability of Acetycholinesterase and 
Butyrylcholinesterase binding reserve sites and 
compare activities of such compounds with 
Galanthamine (used as standard drug). 
 
■ Experimental 
General procedure for the synthesis of 
Benzilidene-benzylamines 
Benzilidene-benzylamines were synthesized 
through the reaction of different aromatic 
aldehyde (1mmol) and aniline (1mmol) mixed in 
toluene use as a solvent. The reactants were taken 
in microwave cuvet and put it in microwave 
irradiation(250W) at room temperature (25 °C) 
and 1 atm pressure with constant shaking. The 
reaction was monitored by TLC after every one 
minut till the completion of reaction. After 
completion of reaction, solvent evaporated in 
rotatory under reduce pressure, and the product 
will be purified by using column 
chromatographic technique. When the pure 
product obtained the reaction mixture were 
cooled at -25 °C temperature in freezer for 48 
hours. Pure crystal of product was obtained. 85% 
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Chemistry of reaction 
Rate of reaction was effected by substituent(s) 
nature on benzaldehyde derivatives and also the 
yield. The electron with drawing groups on 
aromatic ring increase the electrophilic nature of 
carbonyl carbon of benzaldehyde derivatives 
making the attack of nucleophile easier. Opposite 
effect was observed with electron donating groups 
on aromatic ring of benzaldehyde. So the rate and 
yields of Schiff bases with benzaldehyde 
derivatives having EWG as their substituents were 
found to be slightly higher as compared to 
benzaldehyde derivatives with EDG substituents. 
The ligands on the other hand have no significant 
differences in their nucleophilicity towards 
electrophilic carbonyl center as both have EDGs 
attached as their substituents. 
Mechanism 
It has been suggested that the establishment of 
Schiff base takes place in two alterable phases. 
Initially, a single brace of electrons of Nitrogen 
bonded with amine behaves as a nucleophile 
produces a carbinol-amine by attacking the 
electrophilic carbon bonded carbonyl-group. In the 
second stage the chemical reaction is that carbinol-
amine (alcohol) receeds water molecules by 
desiccation and hence establishment of C=N dual 
bond of an imine compound occurs. Abundant of 
Schiff bases are converted to aldehyde or ketone 
and amine by hydrolysis of aqueous acids or bases. 
The slow step that determines the rate of reaction of 
Schiff base formation is dehydration of 
carbinalamine. Due to the basic nature of amines, 
however, the concentration of acid must be 
appropriate. At high concentration of acid, amine 
gets protonated and loses its nucleophilicity as a 
consequence the formation of carbinalamine 
cannot take place because equilibrium is shifted 
to the left side. That’s why Schiff bases are best 
synthesized using weak acids. Carbinalamine 
dehydration can also be achieved using base as a 
catalyst. Though the reaction is not concerted and 
takes place in two steps through an anionic 
intermediate, yet it is rather similar to E2 
elimination of alkyl halides. In general we can 
say that the formation of Schiff bases occurs are 
as a consequence of two contrasting reactions i.e. 
addition reactions trailed by elimination 
reactions[16].  
Anticholinesterase assays 
The butyrylcholinesterase activity (BChE) 
performed on equine serum while the 
acetylcholinesterase(AChE) activity on electric 
eel (Electrophorus electricus) are used for 
synthesized compound 1-6, butyrylcholinesterase 
and acetylcholinesterase assay determination. The 
assay phenomenon is based on butyrylthiocholine 
iodide for BChE and acetylthiocholine iodide by 
AChE hydrolysis promotions. In the process 5-
thio-2-nitrobenzoate anion is formed from 
hydrolysis which can be detected by 
spectrophotometer after complexation with 
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DTNB (5, 5-dithio-bis-nitro-benzoic acid) 
produced a yellow color.  
Solution Preparation 
All the synthesized compound separately 
dissolved in ranging from concentration 62.5 to 
1000 µg/mL in a phosphate buffer 0.1 M solution. 
Prepared a 0.1 M buffer phosphate solution of 
KH2PO4 from 13.6 g/L and K2HPO4 from 17.4 g/L 
having pH value 8.0 ± 0.1 both solutions mixed in a 
6 % KH2PO4 and 94 % K2HPO4 ratio respectively. 
For adjustment of PHmentainance used a potassium 
hydroxide (KOH) solution. The BChE from 7–16 
U/mg and AChE from solid 518 U/mg diluted to 
the final concentration 0.01 U/mL and 0.03 U/mL 
were obtained in pH 8.0 freshly prepared buffer. 
The BTchI of 0.0005 M and ATchI of also 0.0005 
M, DTNB of 0.0002273 M solution in distilled 
water were prepared and eppendorf tubes kept in 
refrigerator at 8 °C. For comparison positive 
control made same concentrations in methanol from 
standard Galanthamine as the compound.  
Spectroscopic Analysis 
For each butyrylcholinesterase activity 
(BChE) and acetylcholinesterase(AChE) activity 5 
µl solution of enzyme to the cuvette added then a 
205 µL test compound added and finally followed 
by a 5 µL DTNB reagent. The mixture of solution 
at 30 °C for 15 minute maintained in controllable 
electrical water bath followed by 5µl substrate 
subsequent addition. Analyzed absorbance at 412 
nm via spectrophotometer of double beam. For the 
positive control 10 µg/mL of standard inhibitor 
cholinesterase a Galanthamine was used while for 
negative control all the reagent utilized except 
compound for test. The reaction time condition 
30
0
C with absorbance is for four minute taken and 
repeated at least three times. Finally rate of 
absorption with time were used for calculation of 








% Enzime Inhibition = 100 - % activity of enzime 
MaxV
V
100 =activity   Enzime %  
Where Vmax is activity of enzyme in absence 
of drug inhibitor and V is reaction rate in presence 
of inhibitor drug. 
IC50 (Median Inhibitory Concentration) 
Estimation 
The butyrylcholinesterase activity (BChE) 
and acetylcholinesterase (AChE) substrate 
inhibited hydrolysis concentration by a 50 % 
(IC50) is different for various compound. 
 
■ Results and Discussion 
Benzilidene-benzylamines were synthesized 
through the reaction of different aromatic 
aldehyde (1mmol) and aniline (1mmol) mixed in 
toluene use as a solvent. The reactants were taken 
in microwave cuvet and put it in microwave 
irradiation(250W) at room temperature (25 °C) 
and 1 atm pressure with constant shaking. The 
reaction was monitored by TLC after every one 
minut till the completion of reaction. After 
completion of reaction, solvent evaporated in 
rotatory under reduce pressure, and the product 
will be purified by using column 
chromatographic technique. When the pure 
product obtained the reaction mixture were 
cooled at -25 °C temperature in freezer for 48 
hours. Pure crystal of product was obtained. 85% 
yields were obtained. 
The pure synthesized compound obtained 
were evaluated via spectrophotometric Ellman 
assay for anticholinesterase inhibition potential 
(BChE and AChE) as shown in table 2. The 
compound 1–6 possess acetylcholinesterase 
inhibition potential in a wide range at tested five 
different concentrations i.e. 62.5, 125, 250, 500, 
1000 μg/mL given in (table 2 and figure 1 and 
figure 2. 
The compound 6 ((E)-4-
((phenylimino)methyl)benzaldehyde) show 
acetylcholinesterase highest inhibition potential at 
concentration of 1000 μg/mL have 77.84±0.32 
percent inhibition activity IC50,62.88 which is 
comparatively greater than a standard 
anticholinesterase a Galanthamine used at 
concentration 62.5 μg/mL, have 74.10±0.90, 
IC50,<0.1 shown in Table 2 and Figure 1. While 
the compound 3 ((E)-N-(4-fluorobenzylidene) 
aniline) at 1000 μg/mL possess 71.62±0.74 and 
compound 6 ((E)-4-((phenylimino)methyl) 
benzaldehyde) at 500 μg/mL have 71.68±0.22 
percent acetylcholinesterase inhibition potential 
which is nearly equal to a standard one 
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Galanthamine. The compound 1 – 6 also possess 
butyrylcholinesterase inhibition at different 
concentration discussed in Table 2 and Figure 2. 
The entire compounds show a wide range of BChE 
activity. The most active compound found is 6 ((E)-
4 ((phenylimino)methyl)benzaldehyde) at 
concentration 1000 μg/mL, have 75.83±1.07  
percent butyrylcholinesterase potency of inhibition 
at IC50,69.48 which is similar to a standard positive 
control a Galanthamine used at concentration 62.5 
μg/mL possess 75.45±0.90 percent potential of 
inhibition.  
Acetylcholine (ACh), is an organic compound 
that works as a neurotranspoter and is important for 
usual purpose of nervous system, which is prepared 
from acetyl-coenzyme A and choline in the 
presence of cholineacetyltransferase (ChAT) as a 
catalyst. Vesicular acetylcholine trannsmitter 
(VAChT) transmittACh into synaptic vesicles 
[17]. Acetylcholine, the firstly ever marked 
neurotranspoter, operates as a neuro regulator in 
the Central Nervous System (CNS) plus 
Peripheral Nervous System (PNS). ACh 
organized with linked neurons in CNS produces a 
cholinergic system, which is motivated to recruit 
inhibitory activities. It stimulates muscles in PNS 
and is one of the most significant neuro 
transporters in the smooth muscles of heart and 





Table 1: Preparation of Benzilidene Benzylamine derivatives in microwave irradiation 
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AChE Percent Inhibition 
(Mean ± SEM) 
IC50 (µg/mL) 
BChE Percent Inhibition 



























































56.45 ± 0.49 
45.75 ± 0.58 
37.51±0.77 
31.53±0.71 
314.78 62.61 ± 0.77 
54.60 ± 0.80 
























































Date are expressed as means ± SEM. Calculated Values significantly different when compared to standard drug Galanthamine at the same 































Compounds activity at Differnet Concentration 
Conc. 62.5 µg/mL Conc. 125 µg/mL Conc. 250 µg/mL 
Conc. 500 µg/mL Conc. 1000 µg/mL 
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In various mammals comprising humansACh 
is hydrolised by two different cholinesterase 
enzymes which are acetylcholinesterase (AChE) 
and butyrylcholinesterase (BChE) [19]. At the 
junction of neuron and muscle, an arising 
membrane confined enzyme AChE (also known as 
true cholinesterase) synchronises the amount of the 
transmitters by deactivating acetylcholine. AChE 
becomes active when Ach in reply to an action 
potential is acquited from the post-synaptic nerve 
process. After transmission of ACh inside the 
synaptic cleave, Ach muddles to acetylcholine 
receptors (AChRs), generally establish on pre-
synaptic cells. The ACh receptor-intermediated 
activity is straightly completed through hydrolysis 
by acetylcholinesterase (AChE) [20, 21]. AChE is 
rich in blood cells, nervous system and muscles 
[22, 23].  
Butyrylcholinesterase is a synthetic 
compound not present in the human body naturally, 
they are known as common cholinesterase or false 
cholinesterase which is an extra cholinesterase that 
hydrolyzes acetylcholine and it specially 
performances on butyrylcholine. BChE is mostly 
present in liver, heart, lung, kidney and intestine 
[23, 24]. Surgeons  considered 
butyrylcholinesterase for its hydrolysis of an 
antibiotic succinylcholine to succinylmonocholine 
and then to succinic acid, the antibiotic is being 
used as a short time inhibitor of the acetylcholine 
receptor in surgical operations [25]. BChE 
controls cholinergic conduction in the lack of 
AChE and hindercarbamate and organophosphate 
inhibitors afore they spread to AChE. BChE also 
aids in the initiation of drugs like bambutarol, 
herion while deactivates others such as 
cocaneasperin, amitriptylene[26].Similarly AChE 
and BChE are combinely obstructed by 1,5-bis(4 
allyldimethylamminopropyl)pentan-3-on di-
bromide and 10-[2-diethylamino-propyl]-
phenothiazide (ethopropazine), [27]. 
 
■ Conclusion 
The current experimental study evaluated on 
synthesized Benzilidene Benzylamine the 
derivative of Schiff bases contain azomethine 
group and have wide range of biological 
activities, for a pathological anti – Alzheimer 
disease. The Anticholinesterase activity is 
performed on different concentration of 
synthesized compound. The percent inhibition 
potential of butyrylcholinesterase and 
acetylcholinesterase is determined using 
spectrophotometric Ellman assay. The entire 
compounds possess a wide range 
butyrylcholinesterase, acetylcholinesterase 
inhibitory potential. The compound 3 ((E)-N-(4-
fluorobenzylidene)aniline) show 



























Compounds activity at Differnet Concentration 
Conc. 62.5 µg/mL Conc. 125 µg/mL Conc. 250 µg/mL 
Conc. 500 µg/mL Conc. 1000 µg/mL 
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percent which is nearly closed to standard positive 
control Galanthamine Anticholinesterase 
74.10±0.90 percent at IC50. While a compound 6 
((E)-4-((phenylimino)methyl)benzaldehyde) at IC50 
show 71.68±0.22, 77.84±0.32 percent inhibitory 
potential comparatively greater than standard 
Galanthamine 74.10±0.90. The 
butyrylcholinesterase (BChE) activity of compound 
6 ((E)-4 ((phenylimino)methyl)benzaldehyde) 
75.83±1.07 percent inhibitory potential which is 
similar to standard compound 75.45±0.90 percent 
butyrylcholinesterase inhibitory activity. These 
synthesized compound show anti – Alzheimer 
potency concluding from Anticholinesterase assay. 
There further analysis can provide more sustainable 
result as compared to a standard one already being 
available.      
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